Literature DB >> 20143779

Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.

Valentina Onnis1, Cenzo Congiu, Emmelie Björklund, Franziska Hempel, Emma Söderström, Christopher J Fowler.   

Abstract

Fatty acid amide hydrolase (FAAH) is the key hydrolytic enzyme for the endogenous cannabinoid receptor ligand anandamide. The synthesis and evaluation for their FAAH inhibitory activities of a series of 18 paracetamol esters are described. Structure-activity relationship studies indicated that the ester (33) with a 2-(4-(2-(trifluoromethyl)pyridin-4-ylamino)phenyl)acetic acid substituent was the most potent analogue in this series. The compound inhibited FAAH activity in a competitive manner with a K(i) value of 0.16 microM. The compound was also able to inhibit the FAAH activity in rat basophilic leukemia cells as assessed by measuring either the hydrolysis of anandamide, the FAAH-dependent cellular accumulation of anandamide, or the FAAH-dependent recycling of tritium to the cell membranes. The compound also inhibited the activity of monoacylglycerol lipase (MGL), the enzyme responsible for the hydrolysis of the endogenous cannabinoid receptor ligand 2-arachidonoylglycerol, with an IC(50) value of 1.9 microM. It is concluded that the compound may be a useful template for the design of potent novel inhibitors of FAAH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143779     DOI: 10.1021/jm901891p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

Review 1.  A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.

Authors:  Rita Scarpelli; Oscar Sasso; Daniele Piomelli
Journal:  ChemMedChem       Date:  2015-10-21       Impact factor: 3.466

Review 2.  The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH).

Authors:  Katerina Otrubova; Cyrine Ezzili; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2011-06-28       Impact factor: 2.823

3.  Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Am Chem Soc       Date:  2011-02-28       Impact factor: 15.419

4.  Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.

Authors:  Cyrine Ezzili; Mauro Mileni; Nicholas McGlinchey; Jonathan Z Long; Steven G Kinsey; Dustin G Hochstatter; Raymond C Stevens; Aron H Lichtman; Benjamin F Cravatt; Edward J Bilsky; Dale L Boger
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

5.  Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.

Authors:  Christopher J Fowler; Emmelie Björklund; Aron H Lichtman; Pattipati S Naidu; Cenzo Congiu; Valentina Onnis
Journal:  J Enzyme Inhib Med Chem       Date:  2012-01-06       Impact factor: 5.051

6.  Design, synthesis, and characterization of α-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolase.

Authors:  Katerina Otrubova; Benjamin F Cravatt; Dale L Boger
Journal:  J Med Chem       Date:  2014-01-23       Impact factor: 7.446

7.  Inhibition of endocannabinoid metabolism by the metabolites of ibuprofen and flurbiprofen.

Authors:  Jessica Karlsson; Christopher J Fowler
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

8.  The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.

Authors:  Christopher P Stanley; William H Hind; Christina Tufarelli; Saoirse E O'Sullivan
Journal:  Pharmacol Res       Date:  2016-09-12       Impact factor: 7.658

9.  Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.

Authors:  Sandra Gouveia-Figueira; Jessica Karlsson; Alessandro Deplano; Sanaz Hashemian; Mona Svensson; Marcus Fredriksson Sundbom; Cenzo Congiu; Valentina Onnis; Christopher J Fowler
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

10.  Involvement of fatty acid amide hydrolase and fatty acid binding protein 5 in the uptake of anandamide by cell lines with different levels of fatty acid amide hydrolase expression: a pharmacological study.

Authors:  Emmelie Björklund; Anders Blomqvist; Joel Hedlin; Emma Persson; Christopher J Fowler
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.